Earlier this week, the government announced that all care centres nationwide will have had the first of two Pfizer-BioNTech COVID-19 injections in the next few days.
Now news has emerged that yet another vaccine will be available to Denmark in the near future.
At the behest of the European Medicines Agency (EMA), the EU Commission has approved the COVID-19 vaccine produced by US firm Moderna.
Data shows that both vaccines reduce the risk of COVID-19 infection by 94-95 percent.
“It’s wonderful that we have yet another vaccine approved that we can introduce into our program,” said Søren Brostrøm, the head of health authority Sundhedsstyrelsen.
“I hope the first Moderna vaccines will be delivered very soon so we can offer vaccinations to even more people in the risk groups.”
READ ALSO: Government reduces gathering limit to five as COVID-19 mutation gathers momentum
Easier to store, transport
Brostrøm went on to say that distributing the Moderna vaccine should be even easier than the Pfizer-BioNTec vaccine.
Unlike the Pfizer-BioNTech vaccine, the Moderna vaccine is not required to be stored in extreme low temperatures.
This also makes it easy to be transported and handled by medical staff – not that there has been any issues thus far.
“It’ll make it even easier to distribute Moderna’s vaccines in all areas of Denmark, the Faroe Islands and Greenland,” said Brostrøm.
